5-alpha Reductase Inhibitors
Showing 1 - 25 of >10,000
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)
Recruiting
- Benign Prostatic Hyperplasia (BPH)
- REZŪM
- alpha blocker and 5-alpha reductase inhibitor
-
Aix-en-Provence, France
- +9 more
Jul 26, 2022
Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease Trial in Boston (Finasteride)
Recruiting
- Benign Prostatic Hyperplasia
- +7 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 26, 2022
Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)
Recruiting
- Prostatic Hyperplasia
- Prostate Cancer
- Prostate hyperplasia medication
- LhRH-antagonist
-
Turku, Finland
- +1 more
Aug 17, 2023
HMG-CoA Reductase Inhibitors on Meibomian Gland Morphology in
Completed
- Meibomian Gland Dysfunction
- +2 more
- Keratograph 5M, Oculus, Wetzlar, Germany
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 12, 2020
Benign Prostatic Hyperplasia Trial in Seoul (combination therapy, alpha blocker monotherapy, 5 alpha reductase inhibitor
Completed
- Benign Prostatic Hyperplasia
- combination therapy
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 28, 2019
Male Urogenital Diseases, Genital Diseases, Male, Prostatic Disease Trial in Hialeah (SoracteLite(TM) TPLA for BPH)
Active, not recruiting
- Male Urogenital Diseases
- +3 more
- SoracteLite(TM) TPLA for BPH
-
Hialeah, FloridaUrology Specialist Group
Jan 24, 2023
C677T Methylenetetrahydrofolate Reductase Mutation
Completed
- Mutation
- infertily evaluation
- (no location specified)
May 16, 2023
Economic Evaluation of Prostatic Urethral Lift
Recruiting
- Benign Prostatic Hyperplasia
- Comparisons between the Prostatic urethral lift (PUL) and the TURP/Laser cohorts
- Comparison between the Prostatic urethral lift (PUL) and the SNDS cohorts
-
Lille, France
- +5 more
Jul 20, 2022
Prostatic Hyperplasia, Prostate Hyperplasia, Prostatic Hypertrophy Trial in Seoul (alpha-blocker or 5-ARI withdrawal,
Recruiting
- Prostatic Hyperplasia
- +2 more
- alpha-blocker or 5-ARI withdrawal
- Maintenance of alpha-blocker and 5-ARI
-
Seoul, Korea, Republic ofGangnam Severance Hospital, Yonsei University College of Medicin
Aug 21, 2021
Genetic DAO Deficiency and Lower Urinary Tract Symptoms
Recruiting
- Lower Urinary Tract Symptoms
- Histamine Intolerance
- LUTS
-
A Coruña, SpainJose Luis Ponce Diaz-Reixa
Jan 9, 2023
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Hypertension Trial in Thessaloniki, London (Anti-hypertensive Medication -)
Completed
- Hypertension
- Anti-hypertensive Medication -
-
Thessaloniki, Greece
- +1 more
Mar 5, 2021
Traumatic Brain Injury Trial (Simvastatin, Placebo drug)
Not yet recruiting
- Traumatic Brain Injury
- Simvastatin
- Placebo drug
- (no location specified)
Oct 6, 2022
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease
Recruiting
- Parkinson Disease
- Dyskinesia, Drug-Induced
- Intravenous Infusion
-
Portland, Oregon
- +2 more
Dec 23, 2022
Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms Trial in Jackson (Prostate artery embolization)
Recruiting
- Benign Prostatic Hyperplasia (BPH)
- Lower Urinary Tract Symptoms
- Prostate artery embolization
-
Jackson, MississippiUniversity of Mississippi Medical center
Feb 22, 2022
Hypercholesterolemia Trial (Ezetimibe, Simvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
Hypercholesterolemia Trial (Ezetimibe, atorvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)
Active, not recruiting
- Prostatic Neoplasms
- Low Grade Prostate Cancer
- Dietary intervention first
- Drug (Dutasteride) intervention first
-
Quebec, Canada
- +1 more
Mar 14, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Manaus (Proxalutamide, Placebo)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Proxalutamide
- Placebo
-
Manaus, Amazonas, BrazilSamel Hospital
Feb 17, 2022
Prostate Hyperplasia Trial in Banha (cyproterone acetate, finasteride, no treatment received)
Completed
- Prostate Hyperplasia
- cyproterone acetate
- +2 more
-
Banhā, Qalyubia, EgyptBenha University
Jul 20, 2021
Postoperative Atrial Fibrillation Trial (Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days
Recruiting
- Postoperative Atrial Fibrillation
- Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative
- No-intervention.
-
Odense, DenmarkOdense University Hospital
Sep 30, 2022
Breast Cancer Female Trial (neoadjuvant chemo (AC-T protocol))
Not yet recruiting
- Breast Cancer Female
- neoadjuvant chemotherapy (AC-T protocol)
- (no location specified)
Aug 17, 2022
Cardiovascular Drugs Adverse Reaction
Recruiting
- Pharmacogenetics
- +2 more
- Oral Anticoagulant, Direct-Acting
-
Zagreb, CroatiaUHC Zagreb
Mar 23, 2022
